Exploring the Global Downstream Processing Market: A Comprehensive Overview

The downstream processing market size has grown rapidly in recent years. It will grow from $27.19 billion in 2023 to $31.07 billion in 2024 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to increasing biopharmaceutical investments, stringent regulatory standards, globalization of biopharmaceutical production, rising incidence of chronic diseases.

The downstream processing market size is expected to see rapid growth in the next few years. It will grow to $51.09 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing demand for biopharmaceuticals, focus on sustainable and green processing, collaborations and partnerships, continuous bioprocessing adoption, increasing demand for personalized medicines. Major trends in the forecast period include digitalization and industry 40 integration, technological advancements, single-use systems, biopharmaceutical industry growth, continuous processing.

Market Overview -
Downstream processing refers to the recovery and purification of a drug substance (DS) from natural sources, such as animal or bacterial cells. It outlines the sequence of steps necessary to create a pure and homogenous protein product from biological components such as cells, tissue culture fluid, or plant tissues.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10155&type=smp

Impact Of Rising Healthcare Expenditure On The Downstream Processing Market
The increasing healthcare expenditure is expected to propel the growth of the downstream processing market going forward. Healthcare expenditure refers to all expenditures for the provision of health services, family planning activities, nutrition activities, and emergency aid designated for health. Downstream processing. Increasing expenditure would boost the sales of downstream processing as it helps in the extraction of a drug substance (DS) from natural sources, such as bacterial or animal cells, and the subsequent purification of the drug substance. For instance, in March 2022, according to the 2021-2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based Department of Health and Human Services department, the annual increase in national health spending was predicted to average 5.1% between 2021 and 2030, reaching approximately $6.8 trillion by 2030. Additionally, throughout the period 2021-2030, Medicare expenditures are expected to expand at a 7.2% annual rate, while Medicaid spending is expected to grow at a 5.6% annual rate. Therefore, the increasing healthcare expenditure is driving the growth of the downstream processing market.

Competitive Landscape -
Major companies operating in the downstream processing market report are Sartorius AG, General Electric Company, Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Repligen Corporation, Minnesota Mining and Manufacturing Company, Lonza Group Ltd., Eppendorf AG, Corning Corporation, Ferner PLC, Ashai Kasei Corporation, Finesse Solutions Inc., MilliporeSigma, Illumina Inc., Pall Corporation, Bio-Rad Laboratories, Charles River Laboratories International Inc., Waters Corporation, Becton Dickinson and Company (BD), Entegris Inc., Novasep, Avantor Sciences, Tecan Group, Agilent Technologies, Bracco S.p.A., Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Novo Nordisk A/S, Ahlstrom-Munksjö Oyj, Grifols S.A., GenScript Biotech Corporation

Surge Of Product Developments In Downstream Processing Market
Product innovations are the key trends gaining popularity in the downstream processing market. Major companies operating in the downstream processing market are focused on developing new technological solutions to strengthen their position in the market. For instance, in September 2022, Tosoh Bioscience LLC, a US-based global chemical and specialty materials company, launched the Octave BIO Multi-Column Chromatography (MCC) system, a holistic multi-column chromatography solution for downstream process intensification. It is an advanced multi-column chromatography system for process development and proof of concept that was specifically created for the intensification of biomolecule purification processes. Wide-ranging requirements can be accommodated by the special modular design, which also makes it possible to take advantage of MCC's resin and buffer cost savings and other real advantages.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/downstream-processing-global-market-report

Key Segments -

The downstream processing market covered in this report is segmented -

1) By Product: Centrifuges, Dryers, Chromatography Systems, Filters, Evaporators, Other Products
2) By Technique: Purification Techniques, Solid-Liquid Separation, Clarification Or Concentration
3) By Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, Other Applications

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.